April Alexander
Nurse Practitioner · Wilkes Barre, PANPI 1225554041
Payments from drug & device makers
Across 99 payments — averaging $18.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$446
- Daiichi Sankyo Inc.$301
- Novo Nordisk$291
- GSK$158
- Pfizer$151
- Abbott$84
- plus $360 from 16 others
What the payments were for
- Food & beverage$1,790100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 20 | $446 |
| Daiichi Sankyo Inc. | 17 | $301 |
| Novo Nordisk | 17 | $291 |
| GSK | 11 | $158 |
| Pfizer | 9 | $151 |
| Abbott | 4 | $84 |
| Eisai Inc. | 2 | $48 |
| Amgen | 2 | $35 |
| Aerin Medical Inc. | 1 | $30 |
| Lilly USA, LLC | 2 | $27 |
| Bayer | 2 | $24 |
| Nestle Healthcare Nutrition Inc. | 2 | $23 |
| Alkermes, Inc. | 1 | $22 |
| Biogen | 1 | $21 |
| Boehringer Ingelheim | 1 | $19 |
| Si-bone, Inc. | 1 | $19 |
| Boston Scientific | 1 | $18 |
| Astellas Pharma US Inc | 1 | $18 |
| AstraZeneca | 1 | $17 |
| Merck | 1 | $16 |
| Philips North America LLC | 1 | $13 |
| Amarin Pharma, Inc. | 1 | $11 |
How this compares
$1,790 in reported general payments places this provider in the 85th percentile of 4,059 nurse practitioner providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 87 | $66,343 |
| JardianceEmpagliflozin | 33 | $30,421 |
| OzempicSemaglutide | 27 | $27,609 |
| TrulicityDulaglutide | 18 | $18,407 |
| XareltoRivaroxaban | 20 | $17,766 |
| Breo ElliptaFluticasone/Vilanterol | 30 | $14,777 |
| Atorvastatin Calcium | 522 | $4,224 |
| Levothyroxine Sodium | 249 | $2,516 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 59 | $2,461 |
| Losartan Potassium | 150 | $1,897 |
| Metoprolol Succinate | 131 | $1,720 |
| Amlodipine Besylate | 211 | $1,598 |
| Metformin Hcl ErMetformin Hcl | 81 | $1,356 |
| SynthroidLevothyroxine Sodium | 26 | $1,211 |
| Rosuvastatin Calcium | 139 | $1,186 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $151 | $66,34387 claims |
| Boehringer IngelheimJardiance | $19 | $30,42133 claims |
| Novo NordiskOzempic | $291 | $27,60927 claims |
| Lilly USA, LLCTrulicity | $27 | $18,40718 claims |
| GSKBreo Ellipta | $158 | $14,77730 claims |
| AbbVieSynthroid | $446 | $1,21126 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,059 nurse practitioner providers in Pennsylvania.
Other nurse practitioner in Wilkes Barre
- Caroline DerichemondWilkes Barre$10K
- Jamie KonschnikWilkes Barre$9K
- Patricia ManganPhiladelphia$360K
- Lisa CocoPhiladelphia$230K
- Elisabeth BaidalPhiladelphia$151K
- Suzanne McGettiganPhiladelphia$108K
- Tracey WileyChambersburg$101K
- Pamela LorditchJohnstown$81K
- Nana BernaskoHershey$81K
- Dawn JeanneratClarion$78K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.